24-hydroxycholesterol has been researched along with Neuroendocrine Tumors in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachi, A; Bernardi, R; Bordignon, C; Coltella, N; Corna, G; Crocchiolo, R; Doglioni, C; Gustafsson, JÅ; Invernizzi, F; Lin, CY; Maggioni, D; Moresco, M; Raccosta, L; Restuccia, U; Russo, V; Soncini, M; Traversari, C | 1 |
1 other study(ies) available for 24-hydroxycholesterol and Neuroendocrine Tumors
Article | Year |
---|---|
24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development.
Topics: Animals; Cell Transformation, Neoplastic; Cholestanetriol 26-Monooxygenase; Cholesterol 24-Hydroxylase; Cytokines; Disease Models, Animal; Disease Progression; Enzyme Activation; Female; Fluorescent Antibody Technique; Gene Expression; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Hydroxycholesterols; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Mice; Mice, Transgenic; Neovascularization, Pathologic; Neuroendocrine Tumors; Pancreatic Neoplasms; Vascular Endothelial Growth Factor A | 2016 |